On-Demand Webinars
Cancer Case Studies
Explore how Organ-on-a-Chip technology has been used to uncover new insights into cancer mechanisms through our on-demand webinars below, with topics ranging from cancer progression, to cell therapy, and even patient-derived models.
Cancer Progression Case Studies
Tumor Intravasation & Metastasis
Here, Dr. Shannon Mumenthaler discusses how she uses Organ-Chips to emulate in vivo tissue structure and the tumor microenvironment (TME) to better understand intravasation, an early step in metastasis.
Epithelial-Stromal Interactions
This webinar explores how the Chip-A1 Accessible Chip expands the applications of Organ-on-a-Chip technology by allowing users to create thicker, multilayered tissues. Elee Shimshoni, PhD, presents a case study of how she used Chip-A1 to model Barrett’s Esophagus and better understand how epithelial-stromal interactions contribute to esophageal cancer progression.
Cancer-Microbiome Interactions
Jens Puschhof, PhD, discusses how organoids can be combined with Organ-on-a-Chip technology for synergized modeling capabilities. In particular, he shares aspects of his team’s work studying the impact of cancer-associated bacteria in colorectal cancer metastasis using Emulate Organ-Chip models.
Cell Therapy Case Study
4-in-1 CAR T Assay
In this data-driven webinar, Emulate Principal Scientist Anita Mehta, PhD, demonstrates the capabilities of the Emulate 4-in-1 CAR T Organ-Chip assay. After watching, you will learn how to use Organ-Chips to model CAR T-cell therapy administration, vascular attachment, migration, and antigen-specific killing—all in a single model.
Patient-Derived Model Case Studies
Colorectal Cancer Progression
In this webinar from Drug Discovery Day 2024, Carly Strelez, PhD, discusses her work using Organ-on-a-Chip technology to better understand colorectal cancer progression and transform approaches to personalized medicine.
Patient-Derived Tumor Models
In this on-demand webinar, Samaneh Kamali, Ph.D., of Champions Oncology describes how she is using Organ-Chips to build complex in vitro models with patient-derived TumorGrafts.